Sofia R Gameiro

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Venues

Journal for immunotherapy of cancer

PloS one

Cells

NPJ breast cancer

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Apr 01 2008

United States

Staff scientist :: Laboratory of Tumor Immunology and Biology

Publications

Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Paul L Chariou, Christine M Minnar, Mayank Tandon, Mary R Guest, Raj Chari, Jeffrey Schlom, Sofia R Gameiro
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PloS one 19 (3) (2024)
Paul L Chariou, Christine M Minnar, Mayank Tandon, Mary R Guest, Raj Chari, Jeffrey Schlom, Sofia R Gameiro
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PloS one 19 (3) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Paul L Chariou, Christine M Minnar, Mayank Tandon, Mary R Guest, Raj Chari, Jeffrey Schlom, Sofia R Gameiro
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PloS one 19 (3) (2024)
Paul L Chariou, Christine M Minnar, Mayank Tandon, Mary R Guest, Raj Chari, Jeffrey Schlom, Sofia R Gameiro
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PloS one 19 (3) (2024)
Paul L Chariou, Christine M Minnar, Mayank Tandon, Mary R Guest, Raj Chari, Jeffrey Schlom, Sofia R Gameiro
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PloS one 19 (3) (2024)
Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian, Kristen Solocinski, Paul L Chariou, Duane H Hamilton, Joshua T Kowalczyk, Michelle R Padget, Sofia R Gameiro, Jeffrey Schlom, James W Hodge
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer immunology, immunotherapy : CII (2023)
Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
Christine M Minnar, Paul L Chariou, Lucas A Horn, Kristin C Hicks, Claudia Palena, Jeffrey Schlom, Sofia R Gameiro
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. Journal for immunotherapy of cancer 10 (6) (2022)
Sofia R Gameiro, Julius Strauss, James L Gulley, Jeffrey Schlom
Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status. Experimental biology and medicine (Maywood, N.J.) 247 (13) (2022)
Karin M Knudson, Kristin C Hicks, Yohei Ozawa, Jeffrey Schlom, Sofia R Gameiro
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. Journal for immunotherapy of cancer 8 (1) (2021)
Kristin C Hicks, Paul L Chariou, Yohei Ozawa, Christine M Minnar, Karin M Knudson, Thomas J Meyer, Jing Bian, Margaret Cam, Jeffrey Schlom, Sofia R Gameiro
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape. Nature communications 12 (1) (2021)
Yohei Ozawa, Kristin C Hicks, Christine M Minnar, Karin M Knudson, Jeffrey Schlom, Sofia R Gameiro
Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa. Oncoimmunology 10 (1) (2021)
Karin M Knudson, James W Hodge, Jeffrey Schlom, Sofia R Gameiro
Rationale for IL-15 superagonists in cancer immunotherapy. Expert opinion on biological therapy 20 (7) (2020)
Kristin C Hicks, Karin M Knudson, Karin L Lee, Duane H Hamilton, James W Hodge, William Douglas Figg, Peter Ordentlich, Frank R Jones, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Karin L Lee, Stephen Charles Benz, Kristin C Hicks, Andrew Nguyen, Sofia R Gameiro, Claudia Palena, John Z Sanborn, Zhen Su, Peter Ordentlich, Lars Rohlin, John H Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, Kayvan Niazi, Jeffrey Schlom, Duane H Hamilton
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. Cancer immunology research 7 (8) (2019)
David B Page, Harry Bear, Sangeetha Prabhakaran, Margaret E Gatti-Mays, Alexandra Thomas, Erin Cobain, Heather McArthur, Justin M Balko, Sofia R Gameiro, Rita Nanda, James L Gulley, Kevin Kalinsky, Julia White, Jennifer Litton, Steven J Chmura, Mei-Yin Polley, Benjamin Vincent, David W Cescon, Mary L Disis, Joseph A Sparano, Elizabeth A Mittendorf, Sylvia Adams
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer. NPJ breast cancer 5 (2019)
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, Harry D Bear, Sangeetha Prabhakaran, Jami Fukui, Mary L Disis, Rita Nanda, James L Gulley, Kevin Kalinsky, Houssein Abdul Sater, Joseph A Sparano, David W Cescon, David B Page, Heather McArthur, Sylvia Adams, Elizabeth A Mittendorf
If we build it they will come: targeting the immune response to breast cancer. NPJ breast cancer 5 (2019)

Sofia R Gameiro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sofia R Gameiro